Bibliography
- Peters BM, Shirtliff ME, Jabra-Rizk MA. Antimicrobial peptides: primeval molecules or future drugs? PLoS Pathog 2010;6:e1001067
- Diamond G, Beckloff N, Weinberg A, et al. The roles of antimicrobial peptides in innate host defense. Curr Pharm Des 2009;15:2377-92
- Wise R; Need BWPU. The urgent need for new antibacterial agents. J Antimicrob Chemother 2011;66:1939-40
- Velkov T, Thompson PE, Nation RL, et al. Structure-activity relationships of polymyxin antibiotics. J Med Chem 2010;53:1898-916
- Vaara M. Novel derivatives of polymyxins. J Antimicrob Chemother 2013;6:1213-19
- Opar A. Bad bugs need more drugs. Nat Rev Drug Discov 2007;6:943-4
- Talbot GH, Bradley J, Edwards JE, et al. Bad bugs need drugs: an update on the development pipeline from the Antimicrobial Availability Task Force of the Infectious Diseases Society of America. Clin Infect Dis 2006;42:657-68
- Rice LB. Challenges in identifying new antimicrobial agents effective for treating infections with Acinetobacter baumannii and Pseudomonas aeruginosa. Clin Infect Dis 2006;43:S100-S5
- Rice LB. Unmet medical needs in antibacterial therapy. Biochem Pharmacol 2006;71:991-5
- Yahav D, Farbman L, Leibovici L, et al. Colistin: new lessons on an old antibiotic. Clin Microbiol Infect 2012;18(1):18-29
- Falagas ME, Kasiakou SK. Colistin: the revival of polymyxins for the management of multidrug-resistant gram-negative bacterial infections. Clin Infect Dis 2005;40:1333-41
- Hancock REW. The bacterial outer membrane as a drug barrier. Trends Microbiol 1997;5:37-42
- Nikaido H. Molecular basis of bacterial outer membrane permeability revisited. Microbiol Mol Biol Rev 2003;67:593
- Hancock REW, Chapple DS. Peptide antibiotics. Antimicrob Agents Chemother 1999;43:1317-23
- Clausell A, Garcia-Subirats M, Pujol M, et al. Gram-negative outer and inner membrane models: insertion of cyclic cationic lipopeptides. J Phys Chem B 2007;111:551-63
- Melo MN, Ferre R, Castanho MARB. OPINION Antimicrobial peptides: linking partition, activity and high membrane-bound concentrations. Nat Rev Microbiol 2009;7:245-50
- Peterson AA, Hancock REW, Mcgroarty EJ. Binding of polycationic antibiotics and polyamines to lipopolysaccharides of pseudomonas-aeruginosa. J Bacteriol 1985;164:1256-61
- Kwa AL, Tam VH, Falagas ME. Polymyxins: a review of the current status including recent developments. Ann Acad Med Singapore 2008;37:870-83
- Nation RL, Li J. Colistin in the 21st century. Curr Opin Infect Dis 2009;22:535-43
- Poudyal A, Howden BP, Bell JM, et al. In vitro pharmacodynamics of colistin against multidrug-resistant Klebsiella pneumoniae. J Antimicrob Chemother 2008;62:1311-18
- Vaara M. Polymyxins and their novel derivatives. Curr Opin Microbiol 2010;13:574-81
- Yau W, Owen RJ, Poudyal A, et al. Colistin hetero-resistance in multidrug-resistant Acinetobacter baumannii clinical isolates from the Western Pacific region in the SENTRY antimicrobial surveillance programme. J Infect 2009;58:138-44
- Tam VH, Schilling AN, Vo G, et al. Pharmacodynamics of polymyxin B against Pseudomonas aeruginosa. Antimicrob Agents Chemother 2005;49:3624-30
- Zavascki AP, Goldani LZ, Li J, et al. Polymyxin B for the treatment of multidrug-resistant pathogens: a critical review. J Antimicrob Chemother 2007;2007;60:1206-15
- Kvitko CH, Rigatto MH, Moro AL, Zavascki AP. Polymyxin B versus other antimicrobials for the treatment of pseudomonas aeruginosa bacteraemia. J Antimicrob Chemother 2011;66:175-9
- Urakawa H, Yamada K, Komagoe K, et al. Structure-activity relationships of bacterial outer-membrane permeabilizers based on polymyxin B heptapeptides. Bioorg Med Chem Lett 2010;20:1771-5
- Vaara M, Fox J, Loidl G, et al. Novel polymyxin derivatives carrying only three positive charges are effective antibacterial agents. Antimicrob Agents Chemother 2008;52:3229-36
- Niu Y, Padhee S, Wu H, et al. Lipo-gamma-AApeptides as a new class of potent and broad-spectrum antimicrobial agents. J Med Chem 2012;55:4003-9